- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- monomer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x 95T: 5-(4-chlorophenyl)-~{N}-(3,5-dimethoxyphenyl)furan-2-carboxamide(Non-covalent)
95T.6: 15 residues within 4Å:- Chain A: Q.355, I.381, F.386, L.1614, T.1658, T.1659, S.1660, I.1706, F.1710, I.1712, M.1713, M.1716, Y.1717
- Ligands: PCW.8, PCW.15
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:F.1710, A:F.1710, A:M.1713
- Hydrogen bonds: A:Q.355, A:Y.1717, A:Y.1717
- pi-Stacking: A:F.386
- 5 x CLR: CHOLESTEROL(Non-covalent)
CLR.7: 5 residues within 4Å:- Chain A: T.679, S.769, W.770, L.1286, I.1290
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:W.770, A:L.1286, A:I.1290
CLR.19: 6 residues within 4Å:- Chain A: K.728, I.735, F.758, L.761
- Ligands: PCW.18, PCW.20
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.758, A:L.761
- Hydrogen bonds: A:K.728
CLR.23: 3 residues within 4Å:- Chain A: T.1215, A.1217, W.1220
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:A.1217, A:W.1220, A:W.1220
CLR.29: 4 residues within 4Å:- Chain A: S.341, M.1494, V.1495, T.1497
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:V.1495, A:T.1497
CLR.30: 10 residues within 4Å:- Chain A: L.393, F.885, L.889, V.1414, I.1418, F.1710, Y.1717, I.1718, I.1721
- Ligands: PCW.15
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:L.393, A:F.885, A:L.889, A:I.1418, A:Y.1717, A:Y.1717
- 7 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PCW.8: 17 residues within 4Å:- Chain A: V.378, L.379, F.382, L.1449, G.1450, W.1539, I.1587, R.1594, T.1595, L.1597, F.1598, L.1600, M.1601, L.1604
- Ligands: 95T.6, PCW.9, LPE.10
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:L.379, A:F.382, A:F.382, A:F.382, A:W.1539, A:W.1539, A:I.1587, A:M.1601, A:L.1604, A:L.1604
- Salt bridges: A:R.1594
PCW.9: 9 residues within 4Å:- Chain A: T.1536, N.1537, G.1538, I.1545, L.1577, M.1601
- Ligands: PCW.8, LPE.11, LPE.17
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:I.1545
- Hydrogen bonds: A:G.1538
PCW.15: 13 residues within 4Å:- Chain A: M.353, T.354, L.846, C.847, G.848, N.878, L.1361, T.1365, L.1410, F.1710
- Ligands: 95T.6, LPE.16, CLR.30
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:L.1361, A:T.1365, A:L.1410, A:L.1410, A:F.1710
- Hydrogen bonds: A:N.878
PCW.18: 11 residues within 4Å:- Chain A: K.728, W.729, F.764, I.777, I.780, G.781, I.1400, F.1404
- Ligands: LPE.16, CLR.19, PCW.20
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.764, A:I.780, A:I.1400
- Salt bridges: A:K.728
PCW.20: 6 residues within 4Å:- Chain A: V.754, Y.1393, M.1394, Y.1397
- Ligands: PCW.18, CLR.19
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.754, A:V.754, A:Y.1397
PCW.21: 7 residues within 4Å:- Chain A: S.1694, P.1695, A.1696, V.1697, I.1700
- Ligands: LPE.22, P5S.31
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.1697, A:I.1700
- Hydrogen bonds: A:A.1696
PCW.28: 8 residues within 4Å:- Chain A: I.1491, T.1492, V.1495, D.1499, Q.1500, S.1501, K.1504, I.1507
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:I.1491, A:T.1492, A:V.1495
- Hydrogen bonds: A:S.1501
- Salt bridges: A:K.1504
- 12 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
LPE.10: 7 residues within 4Å:- Chain A: L.1604, P.1605, L.1607, F.1608, M.1716
- Ligands: PCW.8, LPE.11
No protein-ligand interaction detected (PLIP)LPE.11: 3 residues within 4Å:- Chain A: Y.1442
- Ligands: PCW.9, LPE.10
No protein-ligand interaction detected (PLIP)LPE.12: 4 residues within 4Å:- Chain A: I.251, A.1589, K.1591
- Ligands: LPE.13
No protein-ligand interaction detected (PLIP)LPE.13: 6 residues within 4Å:- Chain A: A.247, T.250, I.251, I.254
- Ligands: LPE.12, LPE.14
No protein-ligand interaction detected (PLIP)LPE.14: 6 residues within 4Å:- Chain A: V.243, K.244, L.246, A.247, T.250
- Ligands: LPE.13
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.243, A:L.246
- Salt bridges: A:K.244
LPE.16: 14 residues within 4Å:- Chain A: I.780, S.783, V.784, T.791, L.794, F.843, L.846, V.881, L.884, I.1403, F.1407, F.1408
- Ligands: PCW.15, PCW.18
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:V.784, A:T.791, A:F.1408
- Hydrogen bonds: A:I.1403
LPE.17: 8 residues within 4Å:- Chain A: Y.373, F.376, L.379, S.1568, T.1570, L.1571, V.1574
- Ligands: PCW.9
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.379
- Hydrogen bonds: A:T.1570
LPE.22: 7 residues within 4Å:- Chain A: N.1216, A.1217, W.1218, L.1255, L.1258, D.1272
- Ligands: PCW.21
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:W.1218, A:W.1218, A:L.1255, A:L.1258
LPE.24: 7 residues within 4Å:- Chain A: G.1167, A.1170, F.1171, F.1615, L.1616, F.1619, F.1647
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.1615, A:L.1616, A:F.1619
- pi-Cation interactions: A:F.1171
LPE.25: 1 residues within 4Å:- Ligands: P5S.31
No protein-ligand interaction detected (PLIP)LPE.26: 4 residues within 4Å:- Chain A: I.680, M.684, F.693
- Ligands: LPE.27
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:I.680
LPE.27: 5 residues within 4Å:- Chain A: I.680, S.690, T.692, M.696
- Ligands: LPE.26
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:I.680
- Hydrogen bonds: A:T.692
- 1 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
P5S.31: 14 residues within 4Å:- Chain A: C.1288, L.1289, W.1292, N.1352, A.1354, M.1355, L.1361, P.1695, A.1696, I.1699, T.1703, I.1707
- Ligands: PCW.21, LPE.25
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:L.1289, A:W.1292, A:W.1292, A:A.1354, A:I.1699, A:I.1699, A:I.1707
- Hydrogen bonds: A:N.1352
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huang, X. et al., Structural basis for high-voltage activation and subtype-specific inhibition of human Na v 1.8. Proc.Natl.Acad.Sci.USA (2022)
- Release Date
- 2022-08-03
- Peptides
- Sodium channel protein type 10 subunit alpha: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- monomer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x 95T: 5-(4-chlorophenyl)-~{N}-(3,5-dimethoxyphenyl)furan-2-carboxamide(Non-covalent)
- 5 x CLR: CHOLESTEROL(Non-covalent)
- 7 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 12 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 1 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huang, X. et al., Structural basis for high-voltage activation and subtype-specific inhibition of human Na v 1.8. Proc.Natl.Acad.Sci.USA (2022)
- Release Date
- 2022-08-03
- Peptides
- Sodium channel protein type 10 subunit alpha: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.